Effect of Enrofloxacin for treatment of bovine anaplasmosis and canine babesiosis

The target of the survey is to study the efficacy of Enrofloxacin 5% and its lower doses used for the therapy of bovine anaplasmosis and efficacy of Enrofloxacin 2, 5 and 5% used for treatment of canine babesiosis. Enrofloxacin 5% has a pronounced therapeutic effect in treatment of anaplasmosis in cattle used at a dose of 1cm3 per 20 and 30 kg of body weight while using the preparation at a dose of 1cm3 per 40 and 50 kg of body weight the therapeutic effect was practically not observed. At the same time Enrofloxacin has no therapeutic efficacy against canine babesiosis.